Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2026)

Kymera Therapeutics (KYMR) has disclosed Interest Coverage Ratio for 8 consecutive years, with 1379.57 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio fell 33.46% year-over-year to 1379.57; the TTM value through Mar 2026 reached 1005.96, up 8.89%, while the annual FY2025 figure was 944.32, 10.13% up from the prior year.
  • Interest Coverage Ratio hit 1379.57 in Q1 2026 for Kymera Therapeutics, down from 1087.73 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 371.38 in Q4 2023 and bottomed at 1402.66 in Q3 2023.
  • Average Interest Coverage Ratio over 5 years is 986.55, with a median of 944.09 recorded in 2025.
  • Year-over-year, Interest Coverage Ratio soared 43.28% in 2023 and then plummeted 268.55% in 2024.
  • Kymera Therapeutics' Interest Coverage Ratio stood at 654.75 in 2022, then skyrocketed by 43.28% to 371.38 in 2023, then tumbled by 268.55% to 1368.73 in 2024, then increased by 20.53% to 1087.73 in 2025, then dropped by 26.83% to 1379.57 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 1379.57, 1087.73, and 944.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.